Table 5.
CD8 Annexin V Levels at Baseline and 6 Years.
| % Annexin V levels (mean ± SD) | CD4 (cells/mm3) | CD8(cells/mm3) | CD4:CD8 Ratio | ||||||
| Baseline | 6 YR | P-value | Baseline | 6 YR | P-value | Baseline | 6 YR | P-value | |
| Low 2.2 ± 2.1 | 625 ± 221 | 1209 ± 164 | 0.001 | 967 ± 386 | 915 ± 308 | 0.766 | 0.76 ± 0.4 | 1.55 ± 0.9 | 0.038 |
| High 17.0 ± 6.0 | 527 ± 132 | 754 ± 320 | 0.098 | 1234 ± 660 | 1172 ± 456 | 0.728 | 0.56 ± 0.36 | 0.7 ± 0.34 | 0.215 |
A repeated measures ANOVA showed a significant difference in the low annexin group for CD4 values from baseline to year 6 with a p value of p ≥ 0.001. The high annexin group CD4 values were not significant from baseline to year 6 with a p value of ≥ 0.098. CD8 values in both the low and high apoptosis groups were not significant for the baseline or 6 year analysis. The CD4:CD8 ratio for the low apoptosis group was significant with a p value of ≥ 0.038, but the ratio for the high apoptosis group was not significant (p ≥ 0.215) after 6 years.